Trial Profile
A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitolisant (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- Acronyms PoC Alcohol
- Sponsors Bioprojet
- 11 Jan 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 18 Jun 2016 New trial record